Trademark: 90605032
Word
CO-EVOLVED MOLECULES
Status Date
Tuesday, February 6, 2024
Filing Date
Friday, March 26, 2021
Published for Opposition
Tuesday, June 14, 2022
5 Pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
Feb 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 6, 2024
Sou Extension 3 Granted
Feb 6, 2024
Sou Extension 3 Filed
Feb 6, 2024
Sou Teas Extension Received
Aug 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 3, 2023
Sou Extension 2 Granted
Aug 3, 2023
Sou Extension 2 Filed
Aug 3, 2023
Sou Teas Extension Received
Feb 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 6, 2023
Sou Extension 1 Granted
Feb 6, 2023
Sou Extension 1 Filed
Feb 6, 2023
Sou Teas Extension Received
Aug 9, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 14, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 14, 2022
Published For Opposition
May 25, 2022
Notification Of Notice Of Publication E-Mailed
May 10, 2022
Approved For Pub - Principal Register
May 9, 2022
Teas/Email Correspondence Entered
May 9, 2022
Correspondence Received In Law Office
May 9, 2022
Teas Request For Reconsideration Received
Nov 29, 2021
Notification Of Final Refusal Emailed
Nov 29, 2021
Final Refusal E-Mailed
Nov 29, 2021
Final Refusal Written
Nov 24, 2021
Teas/Email Correspondence Entered
Nov 24, 2021
Correspondence Received In Law Office
Nov 24, 2021
Teas Response To Office Action Received
Nov 5, 2021
Notification Of Non-Final Action E-Mailed
Nov 5, 2021
Non-Final Action E-Mailed
Nov 5, 2021
Non-Final Action Written
Nov 4, 2021
Assigned To Examiner
Jul 1, 2021
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
